Anavex Life Sciences Q3 EPS $0.08 Beats $(0.08) Estimate
Anavex Life Sciences (NASDAQ:AVXL) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.08) by 200 percent. This is a 150 percent increase over losses of $(0.16) per share from
Anavex did better than experts thought it would this quarter—it made money instead of losing it. This suggests the company might be getting stronger, so it's worth watching to see if this improvement keeps going.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.